- Home
- AMPY vs ARCT Comparison
AMPY vs ARCT Comparison
Compare AMPY & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMPY | ARCT |
|---|---|---|
| Founded | 2011 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 246.9M | 206.0M |
| IPO Year | 2011 | 2019 |
Fundamental Metrics
Financial Performance| Metric | AMPY | ARCT |
|---|---|---|
| Price | $5.57 | $7.46 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $28.33 |
| AVG Volume (30 Days) | ★ 697.6K | 410.8K |
| Earning Date | 06-15-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 232.26 | 20.00 |
| EPS | ★ 1.03 | N/A |
| Revenue | ★ $208,637,000.00 | $82,031,000.00 |
| Revenue This Year | N/A | $0.34 |
| Revenue Next Year | N/A | $93.19 |
| P/E Ratio | $4.97 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.27 | $5.85 |
| 52 Week High | $6.55 | $24.14 |
Technical Indicators
Market Signals| Indicator | AMPY | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 50.50 | 47.75 |
| Support Level | $5.12 | $6.90 |
| Resistance Level | $5.75 | $7.88 |
| Average True Range (ATR) | 0.40 | 0.47 |
| MACD | -0.06 | -0.08 |
| Stochastic Oscillator | 33.83 | 36.02 |
Price Performance
Historical ComparisonAbout AMPY Amplify Energy Corp.
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The company's oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.